Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: Results of a meta- analysis

Archives of Internal Medicine

Volumn 158, Issue 6, 1998, Pages 610-616

  Forgie, Melissa A ^a   Wells, Philip S ^a,b   Laupacis, Andreas ^a   Fergusson, Dean ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; CANCER RECURRENCE; ERYTHROCYTE TRANSFUSION; HEMATOCRIT; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT INDICATION;

BLOOD TRANSFUSION; COHORT STUDIES; ERYTHROCYTE TRANSFUSION; HUMANS; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS; RISK; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032559783     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.6.610     Document Type: Article

References (41)

1. Stehling L, Zauder HL. Autologous blood salvage procedures. Biotechnology. 1991; 19:47-73.
2. Stehling L, Zauder HL. Acute normovolemic hemodilution. Transfusion. 1991; 31:857-868.
3. Fremes SE, Wong BI, Lee E, et al. Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg. 1995;58:1580-1588.
4. Hardy JF, Desroches J. Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth. 1992;39:353-365.
5. Goodnough LT. Clinical application of recombinant erythropoietin in the perioperative period. Hematol Oncol Clin North Am. 1994;8:1011-1020.
6. Goodnough LT, Shafron D, Marcus RE. The impact of properative autologous blood donation on orthopedic surgical practice. Vox Sang. 1990;59:65-69.
7. Woolson ST, Wait JM. Use of autologous blood in total hip replacement. J Bone Joint Surg Am. 1991;73:76-80.
8. Toy PTCY, Strauss RG. Predeposited autologous blood for elective surgery. N Engl J Med. 1987;316:517-520.
9. Sirchia G, Giovanetti AM, McClelland B, Fracchia GN. Safe and Good Use of Blood in Surgery (SANGUIS). Brussels, Luxembourg: European Commission; 1994.
10. Chalmers TC, Celano P, Sacks HS, Smith H Jr. Bias in treatment assignment in controlled clinical trials. N Engl J Med. 1983;309:1358-1361.
11. Jadad AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177-188.
13. Elawad AR, Jonsson S, Laurell M, Fredin HO. Predonation of autologous blood in hip arthroplasty. Acta Orthop Scand. 1991;62:218-222.
14. Lorentz A, Osswald PM, Schilling M, Jani L. Vergleich autologer Transfusion verfahren in der Huftgelenkchirurgie [A comparison of autologous transfusion procedures in hip surgery]. Anaesthesia. 1991;40:205-213.
15. Hoynck van Papendrecht MA, Hop W, Langenhorst BL, Kothe FC, Marquet RL, Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: results from a randomized clinical study. Vox Sang. 1992; 62:102-107.
16. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 1993;342:1328-1333.
17. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 1993;328:1372-1376.
18. Kajikawa M, Nonami T, Kurokawa T, et al. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin. Surgery. 1994;115:727-734.
19. Love TR, Hendren WG, O'Keefe DD, Daggett WM. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg. 1987;43:508-512.
20. Britton LW, Eastlund DT, Dziuban SW, et al. Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg. 1989;47:529-532.
21. O'Hara PJ, Hertzer NR, Krajewski LP, et al. Reductions in the homologous blood requirement for abdominal aortic aneurysm repair by the use of preadmission autologous blood donation. Surgery. 1994;115:69-76.
22. Giurati G, Zanetta G, Caspani L, et al. Autologous blood transfusion in patients undergoing radical hysterectomy. Br J Obstet Gynaecol. 1995;102:64-65.
23. Sandrelli L, Pardini A, Lorusso R, Sala ML, Licenziati M, Alfieri O. Impact of autologous blood predonation on a comprehensive blood conservation program. Ann Thorac Surg. 1995;59:730-735.
24. Toy PT, Kaplan EB, McVay PA, Lee SJ, Strauss RG, Stehling LC, for the Preoperative Autologous Blood Donation Study Group. Blood loss and replacement in total hip arthroplasty: a multicenter study. Transfusion. 1992;32:63-67.
25. Yamada AH, Lieskovsky G, Skinner DG, et al. Impact of autologous blood transfusion on patients undergoing radical prostatectomy using hypotensive anesthesia. J Urol. 1993;149:73-76.
26. Clugston PA, Fitzpatrick DG, Kester DA, Foley B, Germann E. Autologous blood use in reduction mammaplasty: is it justified? Plast Reconstr Surg. 1995;95: 824-828.
27. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol. 1994;12:1859-1867.
28. Goodnough LT, Johnston MF, Ramsey G, et al, for the Transfusion Practices Committee of the American Association of Blood Banks. Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 1990;50:675-683.
29. Kanter MH, van Maanen D, Anders KH, et al. Preoperative autologous blood donations before elective hysterectomy. JAMA. 1996;276:798-801.
30. Miller RD, von Ehrenburg W. Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: con. Transfusion. 1995;35:450-452.
31. Gould SA, Forbes JM. Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: pro. Transfusion. 1995; 35:446-449.
32. Schrieber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transmission of viral infections. N Engl J Med. 1996;334:1685-1690.
33. Linden JV, Kaplan HS. Transfusion errors: causes and effects. Transfus Med Rev. 1994;8:169-183.
34. Linden JV, Paul B, Dressier KP. A report of 104 transfusion errors in New York State. Transfusion. 1992;32:601-606.
35. AuBuchon JP, Popovsky MA. The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion. 1991;31:513-517.
36. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion. 1995;35: 734-737.
37. Egger M, Smith GD. Misleading meta-analysis. BMJ. 1995;310:752-754.
38. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348:1055-1060.
39. Etchason J, Petz L, Keeler E, et al. The cost-effectiveness of preoperative autologous blood donations. N Engl J Med. 1995;332:719-724.
40. Birkmeyer JD, Goodnough LT, AuBuchon JP, et al. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion. 1993;33:544-551.
41. Laupacis A, Fergusson D, for the ISPOT Investigators. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using blood transfusion as the outcome. Anesth Analg. 1997;85:1258-1267.